So true senjo
BTA holders get it from every side.
The drugs are amazing. The rest isn't
BTA have been successful in snatching defeat from the jaws of victory.
They might not care about the share price but I do from the perpective that we will all be robbed the true value of our BTA investment by a predator.
Add the parts up. ( this is rough and Just to prove a point )
Relenza 50 million
Inavir. 231 million
Rsv 50 million
hrv 100 million
Anti bacterial. 25 million
Cash. 60 million
Flunet 50 million
Office and equipment. 10 million
Intellectual property. 10 million
So break it all up today and we have say $ 576 million. That nearly $3.00 a share. Point is the sum of our parts is currently worth more than the whole. That means takeover.
- Forums
- ASX - By Stock
- BTA
- Ann: Phase III prophylaxis trial for CS-8958
Ann: Phase III prophylaxis trial for CS-8958 , page-44
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online